CollPlant Biotechnologies (CLGN) Capital Expenditures (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Capital Expenditures of -$6000.0 for Q1 2026, up 33.33% on a YoY basis from -$4500.0 in Q1 2025, and up 60.0% quarter-over-quarter from -$15000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Capital Expenditures (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Capital Expenditures for 9 years, with the latest figure at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 33.33% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at -$25000.0 (up 93.9% YoY), and the FY2025 full-year result was -$28000.0, up 94.2% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$6000.0, up from -$15000.0 in the prior quarter.
- The five-year high for Capital Expenditures was -$1000.0 in Q3 2025, with the low at -$1.3 million in Q4 2022.
- Historically, Capital Expenditures has averaged -$219529.4 across 5 years, with a median of -$145000.0 in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures sank 140.65% — and 2025, when it surged 99.29%.
- CollPlant Biotechnologies' Capital Expenditures stood at -$1.3 million in 2022, then jumped by 82.03% to -$229000.0 in 2023, then soared by 74.24% to -$59000.0 in 2024, then soared by 74.58% to -$15000.0 in 2025, then soared by 60.0% to -$6000.0 in 2026.
- The last three Capital Expenditures figures came in at -$6000.0 (Q1 2026), -$15000.0 (Q4 2025), and -$1000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | -15,000.00 |
| Dec 31, 2025 | -15,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Dec 31, 2023 | -229,000.00 |